TTRX
Turn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.74
+1.61%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-1229.6%
Return on equity
-49.8%
Return on assets
-102.5%
Return on invested capital
0.00x
Asset turnover
-$4.3M
Cash from operations
$0.34
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026